This inventor holds 1 USPTO granted patent. Top assignee: Lifescan Corporation. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Zbigniew Witko: Innovator in Reagent Test Strip Technology
Introduction
Zbigniew Witko is a notable inventor based in San Jose, CA (US). He has made significant contributions to the field of medical diagnostics, particularly through his innovative work on reagent test strips. His inventions have the potential to enhance the accuracy and efficiency of testing for various analytes in liquid samples.
Latest Patents
Witko holds a patent for a visually-readable reagent test strip. This multilayer reagent test strip is designed to measure the concentration of analyte in a liquid sample applied to it. The sample is guided to several assay areas along the strip, where the analyte reacts with a reagent, resulting in a color change. Each assay area also contains an inhibitor for the color-change reaction, with the inhibitor concentration increasing in successive assay areas. Consequently, the number of areas that change color serves as a measure of the analyte concentration. This test strip is particularly well-suited for measuring glucose levels in whole blood samples.
Career Highlights
Witko is associated with LifeScan Corporation, where he has been instrumental in developing innovative diagnostic solutions. His work has contributed to advancements in the field of glucose monitoring, which is crucial for individuals managing diabetes.
Collaborations
Witko has collaborated with notable colleagues, including Joel Sterling Douglas and Ernest J Kiser. These partnerships have fostered a collaborative environment that encourages innovation and the development of cutting-edge technologies.
Conclusion
Zbigniew Witko's contributions to reagent test strip technology exemplify the impact of innovation in medical diagnostics. His work continues to influence the way glucose levels are monitored, ultimately improving patient care and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
